Format

Send to

Choose Destination
Semin Nephrol. 2014;34(5):532-9. doi: 10.1016/j.semnephrol.2014.08.007.

Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channels.

Author information

1
University of Alabama at Birmingham, Birmingham, AL. Electronic address: ejudd@uab.edu.
2
University of Alabama at Birmingham, Birmingham, AL.

Abstract

Resistant hypertension is a clinically distinct subgroup of hypertension defined by the failure to achieve blood pressure control on optimal dosing of at least 3 antihypertensive medications of different classes, including a diuretic. The pathophysiology of hypertension can be attributed to aldosterone excess in more than 20% of patients with resistant hypertension. Existing dogma attributes the increase in blood pressure seen with increases in aldosterone to its antinatriuretic effects in the distal nephron. However, emerging research, which has identified and has begun to define the function of amiloride-sensitive sodium channels and mineralocorticoid receptors in the systemic vasculature, challenges impaired natriuresis as the sole cause of aldosterone-mediated resistant hypertension. This review integrates these findings to better define the role of the vasculature and aldosterone in the pathophysiology of resistant hypertension. In addition, a brief guide to the treatment of resistant hypertension is presented.

KEYWORDS:

Sodium channel; aldosterone; amiloride; pathophysiology; resistant hypertension

PMID:
25416662
PMCID:
PMC4450367
DOI:
10.1016/j.semnephrol.2014.08.007
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center